Making Metabolites by Mimicking Enzymes

  • ChemPubSoc Europe Logo
  • Author: ChemViews
  • Published Date: 28 April 2011
  • Source / Publisher: ChemCatChem/Wiley-VCH
  • Copyright: Wiley-VCH Verlag GmbH & Co. KGaA
thumbnail image: Making Metabolites by Mimicking Enzymes

Related Societies

As drugs break down in the body, their metabolites can have their own pharmacological, toxicological, and physiological effects. This has lead to complications that have resulted in the withdrawal of several drugs from the market in recent years. Drug metabolism in vivo often involves transformations which currently lack a general counterpart in synthetic organic chemistry. Therefore, drug metabolites cannot be synthesized directly from the drug itself and a different strategy is required.


Frances H. Arnold and colleagues, California Institute of Technology, USA, have engineered two enzyme mimics based on the hepatic P450 oxidases. Many drugs are substrates for these enzymes. The common anti-inflammatory drugs, naproxen and ibuprofen, were converted into their metabolites by the enzyme mimics, generating 1000 and 600 mol of product per mol of enzyme catalyst, respectively.

These enzyme mimics could be used to produce known as well as novel drug metabolites on a preparative scale for their characterization and toxicity testing.

Image: (c) Wiley-VCH


Article Views: 3814

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

Bookmark and Share

If you would like to reuse any content, in print or online, from ChemistryViews.org, please contact us first for permission. more


CONNECT:

ChemistryViews.org on Facebook

ChemistryViews.org on Twitter ChemistryViews.org on YouTube ChemistryViews.org on LinkedIn Sign up for our free newsletter


A product of ChemPubSoc Europe (16 European Chemical Societies)and Wiley-VCH